| 1 | 15389516 | 1,2,4-Thiadiazolidine derivative inhibits nuclear transcription factor-kappaB and its dependent genes activation but induces apoptosis. | Int J Cancer | 2005 Feb 10 |
1 |
| 2 | 19128834 | Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells. | Mol Immunol | 2009 Apr |
3 |
| 3 | 19190325 | Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. | Cancer Res | 2009 Feb 15 |
12 |
| 4 | 19427301 | Novel role of thiadiazolidine derivatives in inducing cell death through Myc-Max, Akt, FKHR, and FasL pathway. | Biochem Pharmacol | 2009 Sep 1 |
2 |
| 5 | 20133937 | Inhibiting TRAF2-mediated activation of NF-kappaB facilitates induction of AP-1. | J Biol Chem | 2010 Apr 9 |
1 |
| 6 | 22081787 | Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma. | J Clin Pathol | 2012 Mar |
1 |
| 7 | 22685262 | Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma. | J Clin Pathol | 2012 Sep |
1 |
| 8 | 24351651 | ATM-dependent chromatin remodeler Rsf-1 facilitates DNA damage checkpoints and homologous recombination repair. | Cell Cycle | 2014 |
2 |
| 9 | 24367492 | RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial. | PLoS One | 2013 |
1 |
| 10 | 24566868 | RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance. | Cancer Res | 2014 Apr 15 |
6 |
| 11 | 24800743 | The RSF1 histone-remodelling factor facilitates DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins. | PLoS Biol | 2014 May |
1 |
| 12 | 28261335 | RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma. | J Cancer | 2017 |
7 |
| 13 | 28843909 | RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis. | Biomed Pharmacother | 2017 Nov |
2 |
| 14 | 29258089 | Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins. | Cell Physiol Biochem | 2017 |
6 |
| 15 | 29480799 | RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer. | Biomedicine (Taipei) | 2018 Mar |
1 |
| 16 | 29565706 | LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway. | Cancer Biol Ther | 2018 Jun 3 |
2 |
| 17 | 30666557 | CRISPR/Cas9 for overcoming drug resistance in solid tumors. | Daru | 2020 Jun |
2 |
| 18 | 31485613 | Rsf‑1 regulates malignant melanoma cell viability and chemoresistance via NF‑κB/Bcl‑2 signaling. | Mol Med Rep | 2019 Oct |
3 |
| 19 | 33156701 | lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway. | Cancer Biother Radiopharm | 2021 Mar |
3 |